#Global Stem Cell Banking Market Segmentation

[industrynewsupdates]

Allogeneic Cell Therapy Market Outlook, Competitive Strategies And Forecast

The global allogeneic cell therapy market size is expected to reach USD 1.72 billion by 2030, expanding at 27.40% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc.Allogeneic cell therapy involves transferring cells from healthy donors to patients to treat chronic diseases such as cancer and cardiovascular diseases. The donor cells can be directly administered to genetically similar patients or added to a cell bank.

The therapies are typically produced in large batches from different donor tissues like bone marrow, and the manufacturing process is similar to that used for protein drugs and other large-scale derived materials. Allogeneic cell therapies offer several benefits over autologous therapies, including being less expensive and their availability as a scalable off-the-shelf product. As a result, the adoption of such therapies is increasing with several biotechnology companies conducting clinical trials treatment of various diseases.

There has been a significant increase in the number of allogeneic cell-based therapy clinical trials in recent years. According to the US National Institutes of Health, the number of mesenchymal stem cell (MSC) based clinical trials using cellular therapy has doubled over the last five years, with 1014 MSC-based clinical trials registered in the government database as either completed or in the process as of July 14th, 2021. This growth in clinical trials, combined with advancements in precision medicine and increased cell therapy production facilities is expected to drive market growth in the coming years.

The rising number of regulatory approvals for allogeneic cell-based therapies is expected to boost market growth over the forecast period. For instance, in October 2021, Enzyvant was granted FDA approval for its RETHYMIC, a single-dose regenerative tissue-based therapy for immunological reconstitution in pediatric patients with congenital athymia.

Gather more insights about the market drivers, restrains and growth of the Allogeneic Cell Therapy Market

Allogeneic Cell Therapy Market Report Highlights

• The stem cell therapies segment held the largest share of 77.00% in 2022. Allogeneic stem cell therapy is most frequently used to treat chronic diseases like blood cancers, leukemia, and lymphoma as well as specialized blood or autoimmune disorders

• By therapeutic area, the hematological disorders segments accounted for the largest share of 58.22% in the global allogeneic cell therapy industry in 2022. Since leading market players are implementing several strategic plans into action to create cutting-edge allogeneic cell therapies for hematological disease treatment

• North America held the largest market share of 80.42% in 2022. This can be attributed to the presence of the major global players in the market, and growing investments from public and private organizations for proteomic and life science research in the region

Allogeneic Cell Therapy Market Segmentation

Grand View Research has segmented the global allogeneic cell therapy market based on therapy type, therapeutic area, and region:

Allogeneic Cell Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)

• Stem Cell Therapies

o Hematopoietic Stem Cell Therapies

o Mesenchymal Stem Cell Therapies

• Non-stem Cell Therapies

o Keratinocytes & Fibroblast-based Therapies

o Others

Allogeneic Cell Therapy Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)

• Hematological Disorders

• Dermatological Disorders

• Others

Allogeneic Cell Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o U.K.

o Germany

o Switzerland

• Asia Pacific

o Japan

o India

o South Korea

• Rest of the World 

List of Key Players in the Allogeneic Cell Therapy Market

• SSM Cardinal Glennon Children's Medical Center

• Cleveland Cord Blood Center

• Duke University School of Medicine

• New York Blood Center

• Clinimmune Labs, University of Colorado Cord Blood Bank

• MD Anderson Cord Blood Bank

• LifeSouth Community Blood Centers, Inc.

• Bloodworks Northwest

• JCR Pharmaceuticals Co., Ltd.

• Sumitomo Pharma Co., Ltd.

• Atara Biotherapeutics

• Mallinckrodt Pharmaceuticals

• Tego Science Inc

• Takeda Pharmaceutical Company Limited

• STEMPEUTICS RESEARCH PVT LTD

• Biosolution Co., Ltd.

• MEDIPOST Co., Ltd.

Order a free sample PDF of the Allogeneic Cell Therapy Market Intelligence Study, published by Grand View Research.

[kristinahertzz]

Cord Blood Banking Services Market

Cord Blood Banking Services Market Size, Share, Trends: Cord Blood Registry (CBR) Systems Leads

Growing Demand for Regenerative Medicine Fuels Market Expansion

Market Overview: 

The global Cord Blood Banking Services Market is projected to grow significantly from 2024 to 2031. North America currently dominates the market, followed by Europe and Asia-Pacific. Key metrics include increasing awareness about stem cell therapies, rising prevalence of chronic diseases, and growing investments in regenerative medicine research. The market is constantly growing due to advancements in cord blood processing and storage technologies, increased applications of cord blood stem cells in many therapeutic disciplines, and higher parental knowledge of the potential benefits of cord blood banking. The increase of cord blood transplantation operations, together with ongoing research into new applications for cord blood stem cells, is driving market growth.

DOWNLOAD FREE SAMPLE

Market Trends: 

The cord blood banking business is witnessing a substantial shift towards hybrid banking models that incorporate components of both commercial and public banking. This practice is gaining traction because it strikes a compromise between private and public storage of cord blood units. Hybrid versions enable families to keep their child's cord blood for personal use while also making a part available for public use or research. This strategy overcomes ethical issues about private banking while increasing the availability of cord blood units for public use. Many cord blood banks are gradually introducing hybrid solutions to meet a greater range of client requests and ethical concerns.

Market Segmentation: 

Private cord blood banking services are the industry's largest section, accounting for more than 60% of the total. This dominance can be ascribed to parents' growing awareness of the potential long-term health benefits of preserving their child's cord blood. Private banking provides exclusive access to banked cord blood units for personal or family purposes, which is one of the primary reasons for its appeal. Recent developments in private cord blood banking include enhanced processing and storage processes, which boost the viability and possible applications of banked cord blood.

Market Key Players: 

Prominent players in the Cord Blood Banking Services Market include Cord Blood Registry (CBR) Systems, Cryo-Cell International, ViaCord, Cordlife Group Limited, Cryo-Save AG, LifeCell International Pvt. Ltd., StemCyte, Global Cord Blood Corporation, Smart Cells International Ltd., and Vita 34 AG. These companies are at the forefront of the industry, continuously innovating and expanding their product portfolios to meet the evolving market demands. Their strategic initiatives and robust distribution networks have enabled them to maintain a strong market presence and drive growth.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[dtgmarketreport]

Blood Bank Market Size & Forecast 2025-2035

The global Blood Bank market, estimated to be valued at USD 21.85 billion in 2024, is estimated to grow up to USD 41.05 billion by 2035 with a CAGR of 5.9% in the period from 2025 to 2035. This market will encompass a wide variety of services, including umbilical cord blood-based stem cell banking, therapies collected through plasma collection, and platelet apheresis for cancer patients.

Blood banks handle critical functions like blood typing, cross-matching for transfusion compatibility, and pathogen testing for safety. These facilities are critical for the collection, processing, storage, and distribution of blood and its components, making them crucial for healthcare by ensuring a steady and safe supply of blood for transfusions and other medical procedures.

Market Dynamics

Mobile Blood Donation units increase mobilization

Mobile blood donation units are changing the face of blood donation. They have been going to schools, workplaces, and community events, where people can donate blood conveniently. With this increased access, blood donation rates are particularly increasing for younger generations. Mobile units also involve the community by partnering with organizations and businesses within the same area, often offering incentives to drive up participation. According to research, mHealth applications can boost donation appointment rates by as much as 22.7%. This could save hundreds of thousands of lives every year.

Challenges of Short Shelf Life for Blood Products

The blood products do have a short shelf life; for example, whole blood only remains available up to 42 days. For platelets, however, they are only available from 5-7 days, thereby presenting a huge problem for inventory control. Most blood remains unutilized and its potential to cause pressure on management concerning collection, donations, and not going about scarce at all times.

AI-Enhanced Blood Management Solutions

Artificial Intelligence and data analytics become indispensable tools in blood management. These technologies help blood banks understand their inventory better, predict donation trends, and optimize donor outreach. Predictive analytics can predict what blood will be needed by whom, thereby reducing short shelf life waste and making donors retain themselves for long periods of time, so that a more reliable blood supply can be ensured.

Expert opinions

According to Robert Scanlon, the head of Blood Bank of Alaska, one of the great successes of mobile drives has been local donations as it has saved lives state-wide.

Kate Fry, the CEO of America's Blood Centers, also spoke about her work on leadership development with Vanderbilt University.

Get A Free Sample Report @Click Here

Market Segmentation

Product Type

The Blood Bank market carries the entire spectrum of blood products for transfusion such as whole blood, red blood cells (RBCs), platelets, plasma, cryoprecipitate, and white blood cells. Due to its essential role in transportation, RBC is primarily the most transfused form of blood product. Longer the shelf life of the products of RBC it easy for handling within blood bank sites as compared to any of other blood products.

Function Type

The major activities of blood banking include collection, processing, transportation, storage, and testing. Testing is the most essential as it ensures that products meant for transfusions are safe and compatible. In the screening procedure, for instance, it involves conducting tests on infectious diseases together with finding out the different blood types to match up the donors with recipients safely.

Regional Analysis

North America : is the largest market in the global blood bank market due to its advanced healthcare infrastructure, stringent safety standards, and the presence of well-established organizations, such as the American Red Cross. Blood centers in this region supply blood products to over 150 million people and serve more than 3,500 hospitals.

Asia-Pacific: The most booming market is that of the Asia-Pacific region, which is driven by enhanced health care spending, growing blood donation awareness, and government programs oriented toward improving blood safety. The countries of China and India are expanding their services of blood banking, therefore greatly contributing to the quick growth experienced in the region. Competitive Environment The Blood Bank market is also highly competitive. Major players are involved in research and development to improve their position. The key players operating in the market are: The American Red Cross NHS Blood and Transplant Canadian Blood Services Vitalant America's Blood Centers Recent development includes a partnership between InVita Healthcare Technologies and BloodHub to enhance blood supply chain automation and Roche's FDA-approved malaria test to screen blood donors in the U.S. Recent Developments March 2024: Roche won the approval from the FDA to use its malaria test for blood donors to boost safety. InVita Healthcare Technologies and BloodHub recently formed a partnership to advance blood management systems in North America.

Conclusion :

 The Blood Bank market is undergoing evolution, characterized by advancements in mobile donation, artificial intelligence, and blood management technologies. Notwithstanding challenges such as the limited shelf lives of blood products, the growth prospects of the market remain robust, propelled by innovations in blood collection, testing, and distribution. North America continues to dominate the market; conversely, the Asia-Pacific region presents substantial growth opportunities. Additionally, the expansion of the market is further enhanced by the rising demand for blood products and government initiatives aimed at improving blood safety on a global scale.

[credenceresearchdotblog]

The Umbilical Cord Blood Banking Market is projected to expand from USD 5,710 million in 2024 to approximately USD 12,239.89 million by 2032, at a compound annual growth rate (CAGR) of 10%.The umbilical cord blood banking market has emerged as a significant segment within the healthcare industry, driven by the increasing awareness of the therapeutic potential of cord blood stem cells. Cord blood, rich in hematopoietic stem cells, has become a valuable resource for treating various life-threatening diseases, including leukemia, lymphoma, and genetic disorders. This article explores the growth, trends, and opportunities in the global umbilical cord blood banking market.

Browse the full report https://www.credenceresearch.com/report/umbilical-cord-blood-banking-market

Market Overview

Umbilical cord blood banking involves collecting, processing, and storing the blood from a newborn's umbilical cord and placenta. This blood is preserved in public or private cord blood banks for potential future medical use. The market has been growing steadily due to advancements in biotechnology, increased public awareness, and the rising prevalence of chronic diseases treatable with stem cell therapy.

According to industry reports, the global cord blood banking market was valued at approximately $XX billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2030. This growth is attributed to the increasing applications of stem cell therapy, government support for regenerative medicine, and technological innovations in banking processes.

Key Market Drivers

1. Expanding Applications of Stem Cell Therapy

Cord blood stem cells are used in over 80 approved medical treatments, including blood cancers, immune deficiencies, and metabolic disorders. Researchers are exploring their potential for treating conditions like cerebral palsy, autism, and diabetes, further driving demand for cord blood banking.

2. Rising Awareness and Education Campaigns

Healthcare providers and public health campaigns have played a crucial role in educating expectant parents about the benefits of cord blood banking. Organizations and governments worldwide are promoting the importance of preserving cord blood for future medical use.

3. Advances in Cryopreservation Technology

Technological advancements have improved the efficiency and reliability of cord blood storage. Modern cryopreservation techniques ensure the viability of stem cells for decades, enhancing the appeal of cord blood banking.

4. Supportive Regulatory Frameworks

Governments in several countries have introduced supportive regulations and funding for cord blood banking initiatives. Public banks, in particular, benefit from these policies, as they contribute to national and international stem cell registries.

Challenges Facing the Market

Despite its promise, the cord blood banking market faces several challenges:

High Costs: The initial collection and storage fees for private cord blood banking can deter many families, especially in low- and middle-income countries.

Limited Awareness in Developing Regions: While awareness is growing in developed countries, many parts of the world remain uninformed about the benefits of cord blood banking.

Ethical Concerns: The use of cord blood in medical treatments raises ethical and religious concerns in certain communities.

Future Outlook

The umbilical cord blood banking market holds immense potential, with opportunities arising from emerging markets, increasing R&D investments, and the expansion of public cord blood banks. The growing interest in personalized medicine and advancements in regenerative therapies are expected to propel the market further.

Key Player Analysis:

Caladrius Biosciences

Cord Blood America, Inc.

Cordlife Group Limited

American Type Culture Collection (ATCC)

Cord Blood Registry (CBR)

China Cord Blood Corporation

Smart Cells International

Esperite N.V.

ViaCord, LLC

Cryo-Cell International, Inc.

Segmentations:

By Storage Option

Public UCB banks

Private UCB banks

By Application

Leukemia

Bone marrow failure syndrome

Metabolic disorder

Lymphoma

Immune deficiencies

By Service Type

Sample Preservation & Storage

Sample Analysis

Sample Processing

Sample Collection & Transportation

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report https://www.credenceresearch.com/report/umbilical-cord-blood-banking-market

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[deshpandeisha]

Introduction to Cell Therapy: Principles and Applications

The global Stem Cell Therapy Market is expected to reach USD 3,693.6 Million by 2027, according to a new report by Emergen Research. The stem cell therapy market is experiencing increased demand due to the rise in the number of clinical trials all over the world. Stem cells are applicable to the development of regenerative medicine, commonly used in the field of dermatology. However, the demand for stem cell applications in the oncology segment will witness the highest growth due to several pipeline projects present for the treatment of cancer or tumors.

The recent advancements in the Stem Cell Therapy industry and trends driving the growth of the market. It is an investigative study covering analysis of market drivers, restraints, challenges, threats, and growth prospects in the global Stem Cell Therapy market. The global Stem Cell Therapy market report is a methodical research of the Stem Cell Therapy market done by extensive primary and secondary research. The fundamental purpose of the Stem Cell Therapy market report is to offer an accurate and strategic analysis of the Stem Cell Therapy business sphere.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/83

Competitive Terrain:

The global Stem Cell Therapy industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Celgene Corporation, Virgin Health Bank,, ReNeuron Group plc, Biovault Family, Mesoblast Ltd., Precious Cells International Ltd., Caladrius, Opexa Therapeutics, Inc., Neuralstem, Inc., Pluristem

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Stem Cell Therapy market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Stem Cell Therapy market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Stem Cell Therapy market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/83

Market Segmentations of the Stem Cell Therapy Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Stem Cell Therapy market on the basis of product, application, and region:

Segments Covered in this report are:

Type Outlook (Revenue, USD Million; 2017-2027)

Allogeneic Stem Cell Therapy

Autologous Stem Cell Therapy

Application Outlook (Revenue, USD Million; 2017-2027)

Regenerative Medicine

Orthopedics

Neurology

Hematology stem cells

Soft tissue injuries

Cardiovascular and myocardial infarction-based

Oncology

Diabetes

Liver Disorder

Others

Drug discovery & development

End-User Outlook (Revenue, USD Million; 2017-2027)

Clinics

Hospitals

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/stem-cell-therapy-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/83

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Geocell Market | Pancreatic Cancer Treatment Market

Latest Report:  Ceramic Tiles Market | Life Science Analytics Market

[latestmarketresearchnews]

Biopreservation Industry Research Report 2030 by Key Growth Drivers, Leading Players Review

The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the longevity and functionality of samples, enabling advancements in medical research and treatment. The market benefits from substantial funding by government bodies and private organizations. These funds facilitate research and development (R&D) activities and drive advancements in biopreservation technologies.

The growing focus on life sciences research and clinical studies has led to innovations in preservation technologies. Companies like BioLife Solutions are expanding their portfolios. In April 2021, BioLife launched a high-capacity controlled freezer tailored for the cell and gene therapy market, addressing the growing demand in this segment. Innovative solutions are reducing the complexity and costs associated with biopreservation. The introduction of multiplex cellular imaging platforms enables better analysis of disease progression, paving the way for tailored diagnostics and treatments in areas like cardiology, gynecology, and point-of-care applications.

The global biopreservation market is on a robust growth trajectory, fueled by advancements in technology, increased funding, and rising demand for biologics and biospecimens. While North America leads the market due to its advanced infrastructure and strong research ecosystem, Asia Pacific is emerging as a dynamic region with rapid adoption of biopreservation techniques. Strategic initiatives by key players and government support are expected to further drive the market’s expansion, positioning biopreservation as a critical component in the future of healthcare and life sciences.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Regional Insights:

North America Biopreservation Market Trends

North America accounted for 45.00% of global revenue in 2022, driven by advanced biomedical research and innovative therapies.

Key Growth Factors:

High prevalence of chronic diseases requiring biopreservation for treatment.

Strong support from organizations like the National Institutes of Health (NIH) and National Cancer Institute (NCI).

Biobanks in the U.S. play a pivotal role in supporting research and clinical trials, further boosting demand for biopreservation technologies.

Asia Pacific Biopreservation Market Trends

Asia Pacific is projected to grow at a CAGR of 30.47% over the forecast period.

Key Drivers:

Rising funding for bio-banking techniques.

Increasing collaborations and partnerships to develop advanced biopreservation services.

Governments in this region are actively investing in R&D and promoting public-private partnerships to bolster the adoption of biopreservation.

Browse through Grand View Research's Category Biotechnology Industry Research Reports.

The global automated and closed cell therapy processing systems market size was valued at USD 1.41 billion in 2024 and is projected to grow at a CAGR of 19.8% from 2025 to 2030.

The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.

Key Companies & Market Share Insights:

The biopreservation market is highly competitive, with major players focusing on strategic initiatives to maintain their market positions. Common strategies include:

Geographical Expansion: Companies are entering untapped markets to capitalize on growth opportunities.

Partnerships and Collaborations: Key players are joining forces with research institutions and governments to expand their services.

In January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service. This initiative provides researchers with access to high-quality tissue samples, highlighting the growing importance of biobanks in advancing medical research.

Key Biopreservation Companies:

Azenta US, Inc.

Biomatrica, Inc.

BioLife Solutions

MVE Biological Solutions

LabVantage Solutions, Inc.

Taylor-Wharton.

Thermo Fisher Scientific, Inc.

Panasonic Corporation

X-Therma Inc.

Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

Biopreservation Industry 2030 Trends, Growth, Revenue, Outlook and Future Estimation

The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the longevity and functionality of samples, enabling advancements in medical research and treatment. The market benefits from substantial funding by government bodies and private organizations. These funds facilitate research and development (R&D) activities and drive advancements in biopreservation technologies.

The growing focus on life sciences research and clinical studies has led to innovations in preservation technologies. Companies like BioLife Solutions are expanding their portfolios. In April 2021, BioLife launched a high-capacity controlled freezer tailored for the cell and gene therapy market, addressing the growing demand in this segment. Innovative solutions are reducing the complexity and costs associated with biopreservation. The introduction of multiplex cellular imaging platforms enables better analysis of disease progression, paving the way for tailored diagnostics and treatments in areas like cardiology, gynecology, and point-of-care applications.

The global biopreservation market is on a robust growth trajectory, fueled by advancements in technology, increased funding, and rising demand for biologics and biospecimens. While North America leads the market due to its advanced infrastructure and strong research ecosystem, Asia Pacific is emerging as a dynamic region with rapid adoption of biopreservation techniques. Strategic initiatives by key players and government support are expected to further drive the market’s expansion, positioning biopreservation as a critical component in the future of healthcare and life sciences.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Regional Insights:

North America Biopreservation Market Trends

North America accounted for 45.00% of global revenue in 2022, driven by advanced biomedical research and innovative therapies.

Key Growth Factors:

High prevalence of chronic diseases requiring biopreservation for treatment.

Strong support from organizations like the National Institutes of Health (NIH) and National Cancer Institute (NCI).

Biobanks in the U.S. play a pivotal role in supporting research and clinical trials, further boosting demand for biopreservation technologies.

Asia Pacific Biopreservation Market Trends

Asia Pacific is projected to grow at a CAGR of 30.47% over the forecast period.

Key Drivers:

Rising funding for bio-banking techniques.

Increasing collaborations and partnerships to develop advanced biopreservation services.

Governments in this region are actively investing in R&D and promoting public-private partnerships to bolster the adoption of biopreservation.

Browse through Grand View Research's Category Biotechnology Industry Research Reports.

The global automated and closed cell therapy processing systems market size was valued at USD 1.41 billion in 2024 and is projected to grow at a CAGR of 19.8% from 2025 to 2030.

The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.

Key Companies & Market Share Insights:

The biopreservation market is highly competitive, with major players focusing on strategic initiatives to maintain their market positions. Common strategies include:

Geographical Expansion: Companies are entering untapped markets to capitalize on growth opportunities.

Partnerships and Collaborations: Key players are joining forces with research institutions and governments to expand their services.

In January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service. This initiative provides researchers with access to high-quality tissue samples, highlighting the growing importance of biobanks in advancing medical research.

Key Biopreservation Companies:

Azenta US, Inc.

Biomatrica, Inc.

BioLife Solutions

MVE Biological Solutions

LabVantage Solutions, Inc.

Taylor-Wharton.

Thermo Fisher Scientific, Inc.

Panasonic Corporation

X-Therma Inc.

Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[marketanalysisdata]

Biopreservation Market Revenue, Share and Growth Rate to 2030

The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.

Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.

In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.

However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.

Application Segmentation Insights:

In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.

The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[marketstudyreport]

Biopreservation Market Competitive Landscape and Industry Analysis 2030

The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.

Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.

In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.

However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.

Application Segmentation Insights:

In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.

The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[harshnews]

Thawing Equipment Market Size, Share, Trends, Growth Opportunities and Competitive Outlook

"Global Thawing Equipment Market – Industry Trends and Forecast to 2029

Global Thawing Equipment Market, By Product (Manual, Automatic), Sample (Blood Products, Ovum/Embryo, Semen, Human Tissue Samples, Organs, Stem Cells, Other), End User (Blood Banks and Transfusion Centers, Hospitals, Research Laboratories, Pharmaceutical Industry, Biobanks, Gene Banks), Application (Therapeutic Applications, Research Applications, Clinical Trials, Other Applications) – Industry Trends and Forecast to 2029.

Access Full 350 Pages PDF Report @

**Segments**

- **Material Type:** - Based on material type, the wicketed bags market can be segmented into polyethylene (PE), polypropylene (PP), polyethylene terephthalate (PET), biodegradable materials, and others. Among these, polyethylene bags are expected to dominate the market due to their cost-effectiveness and versatility in various applications.

- **Closure Type:** - The closure type segment includes options such as resealable zipper closures, heat seal closures, adhesive closures, and others. Resealable zipper closures are gaining popularity due to their convenience and ability to keep the contents fresh for longer durations.

- **End-Use Industry:** - This segment categorizes the wicketed bags market based on end-use industries like food packaging, pharmaceuticals, personal care and cosmetics, industrial, retail, and others. The food packaging industry is anticipated to hold a significant share owing to the increasing demand for convenient and sustainable packaging solutions.

**Market Players**

- **Amcor plc:** - Amcor is a key player in the wicketed bags market, offering a wide range of packaging solutions that cater to various industries. The company focuses on innovation and sustainability to meet the evolving needs of customers.

- **Bemis Company, Inc.:** - Bemis Company is another prominent player known for its advanced packaging technologies, including wicketed bags. The company's strong market presence and focus on product quality have solidified its position in the industry.

- **Berry Global, Inc.:** - Berry Global is a leading manufacturer of wicketed bags, providing customizable packaging solutions to meet specific requirements. The company's robust supply chain and global reach make it a reliable partner for customers worldwide.

- **Mondi plc:** - Mondi is a well-known name in the packaging industry, offering innovative wicketed bag solutions that prioritize sustainability and efficiency. With a strongThe wicketed bags market is witnessing significant growth and evolution driven by various segmentation factors. Material type segmentation plays a crucial role in determining the market landscape. The dominance of polyethylene (PE) bags is primarily attributed to their cost-effectiveness and versatility across different applications. Polypropylene (PP) and polyethylene terephthalate (PET) bags also offer unique advantages, but the eco-friendly trend is fueling the demand for biodegradable materials in wicketed bags. As sustainability becomes a key focus for many industries, the market is likely to witness a shift towards biodegradable options in the coming years.

Closure type segmentation further enhances the customization and functionality of wicketed bags. Resealable zipper closures have gained popularity due to their convenience and ability to maintain product freshness over extended periods. Heat seal closures and adhesive closures also play significant roles in meeting specific requirements of different industries. The choice of closure type can impact consumer convenience, product protection, and overall user experience, making it a crucial element in the wicketed bags market segmentation.

The end-use industry segment categorizes the wicketed bags market based on the applications across various sectors. The food packaging industry is poised to be a key driver of the market growth due to the rising demand for convenient and sustainable packaging solutions. With consumers placing increasing emphasis on convenience and eco-friendliness, wicketed bags offer a practical solution for food packaging companies looking to align with these preferences. Additionally, the pharmaceutical, personal care and cosmetics, industrial, retail, and other industries also contribute to the diverse applications of wicketed bags, showcasing the market's versatility and adaptability to different market demands.

Market players such as Amcor plc, Bemis Company, Inc., Berry Global, Inc., and Mondi plc are key contributors to the growth and innovation in the wicketed bags market. These companies bring a wealth of experience, technological expertise, and a strong focus on sustainability to the table, catering to the**Global Thawing Equipment Market**

- **Product:** - The thawing equipment market is segmented based on product types into manual and automatic thawing equipment. Both manual and automatic thawing equipment play a crucial role in various industries such as blood banks, hospitals, research laboratories, and the pharmaceutical industry, catering to different needs and requirements.

- **Sample:** - The sample segment categorizes the thawing equipment market based on the types of samples being thawed. This includes blood products, ovum/embryo, semen, human tissue samples, organs, stem cells, and other sample types. Each sample category requires specific thawing conditions and protocols, driving the demand for specialized thawing equipment in the market.

- **End User:** - The end-user segment of the thawing equipment market entails blood banks and transfusion centers, hospitals, research laboratories, the pharmaceutical industry, biobanks, and gene banks. Each end user has unique thawing needs based on the samples being handled, highlighting the importance of tailor-made thawing equipment solutions for different applications.

- **Application:** - The application segment further refines the market by categorizing the use of thawing equipment into therapeutic applications, research applications, clinical trials, and other applications. Thawing equipment plays a critical role in ensuring the integrity and viability of samples for various applications, making it a key component in the healthcare and research sectors.

The global thawing equipment market is witnessing significant growth and

Countries Studied:

North America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)

Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)

Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)

Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

 Objectives of the Report

To carefully analyze and forecast the size of the Thawing Equipment market by value and volume.

To estimate the market shares of major segments of the Thawing Equipment

To showcase the development of the Thawing Equipment market in different parts of the world.

To analyze and study micro-markets in terms of their contributions to the Thawing Equipment market, their prospects, and individual growth trends.

To offer precise and useful details about factors affecting the growth of the Thawing Equipment

To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Thawing Equipment market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.

Key questions answered

How feasible is Thawing Equipment Market for long-term investment?

What are influencing factors driving the demand for Thawing Equipment near future?

What is the impact analysis of various factors in the Global Thawing Equipment market growth?

What are the recent trends in the regional market and how successful they are?

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America

Browse Trending Reports:

Forage Harvester Market Calcify Uremic Arteriolopathy Drug Market Alexipharmic Drugs Market Resectoscope Market Coal To Liquid Market Air Electrode Battery Market Power Sports Batteries Market Body Scrub Market Cataplexy Treatment Market Alveolar Capillary Dysplasia Treatment Market Quantum Computing Market Control Valves Market Hemodialysis Peritoneal Dialysis Market Breathable Films Market Utility Locator Market Food Humectants Market Electronic Safety System Market Reporter Gene Assay Market Security Assertion Markup Language Saml Authentication Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[global-research-report]

Cell Separation Technologies in the U.S.: Market Dynamics and Regional Insights

The U.S. cell separation market size was estimated at USD 3.30 billion in 2023 and is expected to grow CAGR of 7.7% from 2024 to 2030. Cell separation plays a crucial role in different applications such as in-vitro diagnostics, biologics designing and development, therapeutic protein production, and other research applications.

Increasing prevalence of chronic diseases, such as cancer, and extensive R&D activities by key companies to develop novel cell & gene therapies are expected to fuel the demand for cell separation solutions. As per the American Cancer Society’s estimates, in 2021, around 1.9 million new cases of cancer were estimated to be diagnosed in the U.S., with over 608,570 cancer-related deaths. Biologics is recognized as the fourth major method to treat cancer efficiently.

Furthermore, biologics play a key role in the development of precision medicines. The U.S. has seen significant growth in biologics in recent years. It has exported 6,355 patents to China, 11,742 to Japan, and 72 to Germany over the past three decades. As a result, around 15 new biologics were approved by the U.S. FDA in 2022, including cancer therapeutics such as Kimmtrak, Opdualag, and Imjudo.

In 2023, the U.S. cell separation market accounted for over 36% of the global cell separation market. The presence of major companies such as Thermo Fisher Scientific, BD, & Danaher in the country and their strategic initiatives are anticipated to fuel the market growth. For instance, in February 2021, Thermo Fisher Scientific acquired cell sorting assets from Propel Labs. As per the deal, the company added a new Bigfoot Spectral Cell Sorter of Propel Labs to its capabilities.

U.S. Cell Separation Market Report Highlights

Consumables antibodies held the largest share of 60.2% in 2023 and this is also expected to witness the fastest growth rate over the forecast period. T

Animal cells held the largest market share of 52.4% in 2023. Drug discovery and development involve the use of animal cells to examine preliminary toxicity, efficacy, and pharmacokinetics of new drug molecules. 

Centrifugation held the largest market share of 40.6% in 2023. Cell separation often involves the use of differential centrifugation and density gradient centrifugation.

Biotechnology and biopharmaceutical companies occupied the largest revenue share of 42.1% in 2023. The segment is also expected to exhibit the fastest growth rate during the forecast period.

U.S. Cell Separation Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. cell separation market report based on product, cell type, technique, application, and end-use.

Product Outlook (Revenue, USD Million, 2018 - 2030)

Consumables

Reagents, Kits, Media, and Sera

Beads

Disposables

Instruments

Centrifuges

Flow Cytometers

Filtration Systems

Magnetic-activated Cell Separator Systems

Cell Type Outlook (Revenue, USD Million, 2018 - 2030)

Human Cells

Animal Cells

Technique Outlook (Revenue, USD Million, 2018 - 2030)

Centrifugation

Surface Marker

Filtration

Application Outlook (Revenue, USD Million, 2018 - 2030)

Biomolecule Isolation

Cancer Research

Stem Cell Research

Tissue Regeneration

In Vitro Diagnostics

Therapeutics

End-use Outlook (Revenue, USD Million, 2018 - 2030)

Research Laboratories and Institutes

Biotechnology and Biopharmaceutical Companies

Hospitals and Diagnostic Laboratories

Cell Banks

Order a free sample PDF of the U.S. Cell Separation Market Intelligence Study, published by Grand View Research.

[tamanna31]

Biopreservation Market by Regions, Type & Applications During 2023-2030

Biopreservation Market Size & Trends

The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 

Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market 

Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.

In recent years, there has been an upsurge in demand for use of biopreservation to develop biological products in R&D of various sectors such as immunotherapies, vaccine production, antibody production, enzyme technology, and biologically produced chemicals. This impact is due to the rising number of chronic disease incidences globally. For instance, according to the Centers for Disease Control and Prevention, cardiovascular disorders and cancer are among the leading causes of disease-related mortality in adults in the U.S.  

Furthermore, the government and private sectors have shown interest and supported funding activities in research & development, leading to immense market developments. In recent years, the growing demand for preserving stem cells and developing biological medicines and products has gained investors' focus in this field. This considerable healthcare spending is expected to fuel market growth during the forecast period.

However, the growing biopreservation market is associated with challenges such as the unavailability of skilled professionals and the lack of stringent cybersecurity measures. The high cost of labor training and software standardization are some of the contributing factors. These challenges could potentially impact overall market growth.

Biopreservation Market Segmentation

Grand View Research has segmented the global biopreservation market report on the basis of product, application, and region:

Product Outlook (Revenue, USD Billion, 2018 - 2030)

Equipment

Freezers

Refrigerators

Consumables

Vials

Straws

Microtiter Plates

Bags

Liquid Nitrogen

Media

Pre-formulated

Home-brew

Laboratory Information Management System (LIMS)

Application Outlook (Revenue, USD Billion, 2018 - 2030)

Regenerative Medicine

Cell Therapy

Gene Therapy

Others

Bio-banking

Human Eggs

Human Sperms

Veterinary IVF

Drug Discovery

Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

China

Japan

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

Browse through Grand View Research's Biotechnology Industry Research Reports.

The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Key players in the market are opting for strategic initiatives, funding facilities for geographical expansion, partnerships, mergers and acquisitions in key regions. For instance, in January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service in Qatar to provide researchers the access to high-quality tissue samples. Some of the key players in the biopreservation market include:

Azenta US, Inc.

Biomatrica, Inc.

BioLife Solutions

MVE Biological Solutions

LabVantage Solutions, Inc.

Taylor-Wharton.

Thermo Fisher Scientific, Inc.

Panasonic Corporation

X-Therma Inc.

PrincetonCryo.

Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[allmarketnews]

Biobanking Market Future Aspect Analysis and Current Trends by 2024 to 2034

The Biobanking Market is crucial to the advancement of biomedical and translational research because it facilitates the collection and preservation of biological samples, including blood, tissues, and nucleic acids, which are then made available for use in studies aimed at identifying disease-relevant biomarkers. These biomarkers can then be utilized for diagnosis, prognosis, and drug response prediction. A key factor propelling the market is the increase in the quantity of research projects in this sector. These segment’s research efforts are supported by government funding available for stem cell therapies, regenerative medicine, and cell and gene therapy. Aside from this, the growing popularity of cord blood banking will support the expansion of this industry.

The Biobanking market is predicted to develop at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2034, when it is projected to reach USD 184.28 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 81.50 Billion in 2024.

Know More About Biobanking Market, Download Sample Report: https://wemarketresearch.com/reports/request-free-sample-pdf/biobanking-market/1124

Biobanking refers to the organized collection and maintenance of biological specimens and their associated data. These banks store a variety of samples, such as human tissues, blood, DNA, and other biological materials, along with crucial information about the donors, including their medical history, lifestyle, and genetic data. This systematic storage allows researchers to access high-quality, well-documented specimens for their studies.

Key Market Players

The Biobanking Market is dominated by a few large companies, such as

Thermo Fisher Scientific Inc.

PHC Holdings Corporation

Becton, Dickinson and Company

QIAGEN N.V.

Merck KGaA

Sampled

Avantor, Inc.

Cryoport, Inc.

Tecan Trading AG

Azenta, Inc.

Greiner Holding AG

Others

Global Biobanking Market- Segmental Analysis

By Sample Type

Human Tissues

Stem Cells

Other Biological Samples

By Application

Therapeutics

Research

Clinical Trials

By Storage Type

Manual Storage Systems

Automated Storage Systems

By End User

Pharmaceutical and Biotechnology Companies

Academic Research Institutes

Hospitals and Diagnostic Laboratories

Purchase a Copy of this Biobanking Market research report at@ https://wemarketresearch.com/purchase/biobanking-market/1124?license=single

Challenges in Biobanking

Standardization: Developing standardized procedures for sample collection, processing, and storage is essential to ensure the quality and comparability of specimens across different biobanks.

Funding and Sustainability: Maintaining biobanks requires significant financial resources. Securing long-term funding and demonstrating the value of biobanks to stakeholders are ongoing challenges.

Technological Advances: Rapid advancements in technology, such as genomics and data analytics, require biobanks to continually update their infrastructure and capabilities.

Interoperability: Facilitating data sharing and collaboration between biobanks, both nationally and internationally, is crucial for maximizing the potential of biobanked samples.

The Future of Biobanking

The future of biobanking is bright, with several promising trends and developments:

Integration with Digital Health: The integration of biobanks with digital health technologies, such as electronic health records (EHRs) and wearable devices, can provide more comprehensive data and enhance research capabilities.

Global Collaboration: Increasing international collaboration and data sharing among biobanks will help address global health challenges and accelerate medical research.

Ethical Innovations: Continued advancements in ethical frameworks and governance models will help address the complex ethical issues associated with biobanking.

Personalized Medicine: Biobanks will play a critical role in the continued development of personalized medicine, providing the samples and data needed to tailor treatments to individual patients.

Biobanking Industry: Regional Analysis

North America Market Forecast

North America dominate the Biobanking Market with the highest revenue generating market with share of more than 47%. Leading biobanking companies, robust government support, and advances in personalized medicine foster growth. Extensive R&D activities and a high prevalence of chronic diseases also contribute to the market's expansion.

Europe Market Statistics

Europe’s biobanking market thrives due to its robust regulatory frameworks, strong healthcare systems, and substantial research funding. The region's collaborative research initiatives and cross-border projects enhance biobank operations and data sharing. Supportive policies and funding for innovative research drive the growth and efficiency of biobanks across Europe.

Conclusion

Biobanking is a cornerstone of modern medical research, offering invaluable resources for understanding diseases, developing new treatments, and improving public health. By addressing ethical, legal, and operational challenges, and embracing technological advancements, biobanks can continue to drive scientific discoveries and enhance healthcare outcomes worldwide.

About We Market Research:

WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Contact Us:

Mr. Robbin Joseph

Corporate Sales, USA

We Market Research

USA: +1-724-618-3925

Websites: https://wemarketresearch.com/

Email: sales@wemarketresearch.com

[wellnessweb]

Global Mesenchymal Stem Cells Market Overview

The Mesenchymal Stem Cells Market size was estimated at USD 3.11 billion in 2023 and is expected to reach USD 8.22 billion by 2031 with a growing CAGR of 12.93% during the forecast period of 2024-2031.The Mesenchymal Stem Cells (MSCs) market is poised at the intersection of groundbreaking research and therapeutic innovation, heralding a new era in regenerative medicine.

With their remarkable potential to differentiate into various cell types, MSCs have captivated the biomedical field, offering promising avenues for treating a spectrum of diseases from orthopedic injuries to autoimmune disorders. As scientific understanding deepens and clinical trials expand, the market for MSC therapies anticipates exponential growth, driven by robust investment in biotechnology and increasing healthcare demand for effective, personalized treatments. This burgeoning market not only holds the key to transformative therapies but also represents a pivotal frontier in harnessing the body's own healing mechanisms for improved patient outcomes worldwide.

Get Sample Report @ https://www.snsinsider.com/sample-request/3948

Market Scope & Overview

The most recent Mesenchymal Stem Cells Market  report offers accurate data on the market's size, share, and capacity for production, demand, and growth over the coming year. According to market research, the market is changing quickly, and both the impact on the present and the future are being examined. The market research team conducted thorough primary and secondary research to gather the relevant market data.

The market size and value for each industry, channel, and other sector are discussed in the research. It also takes into account the elements and traits that could affect the expansion of the market's sales. The market's present and future states are carefully examined in the worldwide Mesenchymal Stem Cells Market  research report.

Market Segmentation Analysis

By Products and Services

Products

Cells & Cell Lines

Kits, Media, & Reagents

Others

Services

By Workflow

Cell Sourcing & Isolation

Culture & Cryopreservation

Differentiation

Characterization

By Type

Autologous

Allogeneic

By Source of Isolation

Bone Marrow

Cord Blood

Peripheral Blood

Fallopian Tube

Fetal Liver

Lung

Adipose Tissues

By Indication

Bone And Cartilage Repair

Cardiovascular Disease

Inflammatory And Immunological Diseases

Liver Diseases

Cancer

GvHD

Others

By Application

Disease Modelling

Drug Development & Discovery

Stem Cell Banking

Tissue Engineering

Toxicology Studies

Others

COVID-19 Impact Analysis

The worldwide economy is significantly impacted by the coronavirus outbreak. The most recent COVID-19 scenario analysis is included in this Mesenchymal Stem Cells Market  research report. The top businesses, distributors, and supply chain organizations in the sector are also examined in the report.

Regional Outlook

North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa are the five geographic divisions of the market. The Mesenchymal Stem Cells Market report examines each regional market in great detail and sheds light on the key factors influencing it. The research takes into account factors such as market size and share, import/export ratios, supply/demand ratios, consumer demand ratios, technological advancements, R&D, infrastructure development, and a strong market presence across the board.

Competitive Analysis

To give readers a greater understanding of the important players, the study report covers cutting-edge research approaches including SWOT and Porter's Five Forces analysis. Additionally, it includes crucial data on the economy, global positioning, product portfolios, earnings, gross profit margins, and scientific and technology advancements. The key industry partnerships, product launches, and acquisitions are the subject of the Mesenchymal Stem Cells Market  research.

Key Reasons to Purchase Mesenchymal Stem Cells Market  Research Report

Market research contains critical development status, growth rates, evaluations of the competitive environment, and data on international marketing.

The research report offers a comprehensive view of the worldwide competitive climate as well as crucial details on the leading rivals and their projected future growth.

Conclusion

For industry participants and other stakeholders looking for a thorough analysis of the current market dynamics as well as realistic estimates, the Mesenchymal Stem Cells Market  research report will be a valuable resource.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in re framing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Nasal Drug Delivery Market Growth Drivers

DNA Synthesis Market Growth Drivers

Osteoporosis Treatment Market Growth Drivers

Immunomodulators Market Growth Drivers

Proteomics Market Growth Drivers

[market-insider]

Exploring the Cell Harvesting System Market: Detailed Insights on Size, Share, Growth Potential

The global cell harvesting system market size is expected to reach USD 13.22 billion by 2030, registering a CAGR of 14.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for stem cell-based therapies, owing to the growing base of aging population and increasing prevalence of chronic diseases, is one of the major factors contributing toward lucrative market growth.

Cell Harvesting System Market Report Highlights

The peripheral blood segment dominated the market in terms of revenue share of 31.4% in 2023 pertaining to the widespread use of peripheral blood stem cell (PBSC) harvesting driven by its slightly invasive nature and the increasing demand for stem cell treatments.

In 2023, hospitals dominated the cell harvesting market mainly for spending on storage units and cryogenic preservation techniques. Besides, the research and development conducted by hospitals is also a significant factor for the segment growth.

North America cell harvesting system market accounted for a market share of 39.4% in 2023. The presence of a highly developed medical and healthcare infrastructure fuels a significant share of the cell harvesting market over the forecast period.

For More Details or Sample Copy please visit link @: Cell Harvesting System Market Report

Growing investment in stem cell research is one of the high impact rendering drivers contributing to the demand for stem cells, which thereby contributes to the growth of the cell harvesting system market. There has been a significant rise in the stem cell transplantation rate globally, which is another major driver for increasing demand across the globe. Growth in autologous stem cell transplantation along with increasing stem cell banking is stimulating demand for cell harvesting system.

The potential use of stem cells in regenerative medicine, such as in the case of cancer, trauma, congenital diseases, etc., is also one of the factors contributing to the demand for stem cells for research, thereby contributing toward the growth of cell harvesting system market across the globe. The rising prevalence of certain diseases such as cancer is expected to drive the growth of this market over the forecast period.

List of major companies in the Cell Harvesting System Market

Argos Technologies, Inc.

Perkin Elmer, Inc.

Brand GmBh+ CO KG

Arthrex, Inc.

Avita Medical

Tomtec

Terumo Corporation

Teleflex, Inc.

Bertin

Sartorius AG

For Customized reports or Special Pricing please visit @: Cell Harvesting System Market Analysis Report

We have segmented the global cell harvesting system market on the basis of on type, application, end-use, and region.

[latestmarketresearchnews]

Biopreservation Market Growth Drivers With Outlook And Opportunity Forecast To 2030

The global biopreservation market was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. The rapid growth of this market is driven by a variety of factors, including the extensive use of biopreservation in hospitals, research labs, and healthcare facilities. Increased funding from both government entities and private organizations in healthcare is bolstering this growth, alongside a rise in research and development activities. In addition, advancements in product development are contributing to the expanding market. For instance, BioLife Solutions introduced a high-capacity controlled freezer in April 2021, targeting the cell and gene therapy market, which enabled the company to extend its product offerings.

Despite the market's expansion, the COVID-19 pandemic posed significant challenges, such as supply chain disruptions, shortages of raw materials, and interruptions to research activities. However, the pandemic also accelerated the development of novel biologics and vaccine technologies, creating a surge in demand for biologics manufacturing and preservation. As a result, opportunities for biopreservation are expected to increase, further boosting the market.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Biopreservation involves maintaining the integrity and functionality of biological materials such as stem cells, DNA, tissues, and organs by storing them at specific temperatures. This process extends their viability outside of their natural environment. Recent technological innovations, including microarrays and the incorporation of predictive models like hybrid models and API algorithms, have significantly reduced the time, cost, and complexity of biopreservation processes. These technological advancements are enhancing efficiency and performance across the industry.

Moreover, multiplex cellular imaging platforms are emerging as a transformative technology in the biopreservation field. These platforms improve the ability to monitor disease progression and offer insights into suitable diagnostic and treatment measures. They are particularly useful for specific healthcare areas like cardiology, gynecology, and point-of-care diagnostics. As these innovations progress, the role of biopreservation in modern healthcare is expected to expand.

Product Segmentation Insights:

The equipment segment dominated the biopreservation market in 2022, accounting for 78.75% of the market share. This is largely due to the growing demand for bio-banking services, which are used to preserve stem cells, DNA, plasma, and tissue cultures. The ability of biopreservation equipment to provide adequate storage capacity while requiring minimal maintenance has contributed to the widespread adoption of these solutions. As more healthcare providers and research facilities adopt biopreservation technologies, the equipment segment is expected to continue its strong performance.

The media segment, although smaller in market share, has significant growth potential. It is a crucial element of the biopreservation process, ensuring that biological materials are preserved effectively. The media segment is projected to grow at a remarkable CAGR of 29.99% from 2023 to 2030. Media applications are becoming more sophisticated, offering features that enhance research by enabling better data sharing and analysis. These advancements allow researchers to improve their capabilities in diagnosing, monitoring, and treating various health conditions, which is expected to drive significant market growth over the forecast period. As a result, the media segment will play an increasingly important role in advancing the overall effectiveness and efficiency of biopreservation.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.